Infectious Disease Control
Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand
- Introduces new synthetic cholesterol product nine months ahead of schedule - Offers high purity, scalability, and consistent quality - One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine DARMSTADT,...
2021-05-26 20:00
2920
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19
The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted Enrollment in opaganib's global Phase 2/3 study in hospitalized patients with severe COVID-19 is almost 100% complete RHB-107's ongoing Phase 2/3 study is enrolling U.S. non-hospitalized p...
2021-05-26 19:12
9760
TCI Co., Ltd. named as one of Asia's fastest growing companies by The Financial Times
TAIPEI, May 25, 2021 /PRNewswire/ -- TCI Co., Ltd. (8436. TWO), a leading nutraceutical ODM company, has earned a position in the exclusive ranking of High-Growth Companies inAsia-Pacific 2021. TCI, has been ranked top 15 among Taiwanese companies, registering an absolute growth rate of 207.6% an...
2021-05-26 11:07
2853
Aussie LegalTech Startup Goes Global With COVID-19 Diagnosis Tool
* Australian LegalTech startup, Rulestar, is taking its automation platform global and expanding beyond the legal industry. * Rulestar has released an automated COVID-19 diagnosis tool as a new proof-of-concept product. * This demonstrates how automation technologies can improve decision-mak...
2021-05-25 22:25
1876
Aon's New Vaccine Supply Chain Solution to Benefit Response Fund for the World Health Organization
Aon will donate all 2021 revenues from new solution that protects global COVID-19 vaccine shipments to the COVID-19 Solidarity Response Fund. CHICAGO, May 25, 2021 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and hea...
2021-05-25 21:00
6823
Aiming for Zero Leprosy: 30th Anniversary of World Health Assembly Resolution and WHO Global Leprosy Strategy 2021-2030 Are Opportunities to Accelerate Efforts against the Disease
TOKYO, May 24, 2021 /PRNewswire/ -- Thirty years ago this month, the World Health Assembly (WHA) adopted a resolution to eliminate leprosy as a public health problem. Today, as the 74th WHA gets under way, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa is urging countries not to o...
2021-05-24 15:00
1539
Chinese president addresses global health summit
BEIJING, May 24, 2021 /PRNewswire/ -- Chinese President Xi Jinping attended the Global Health Summit and delivered a speech via video link inBeijing on Friday.   The summit was co-hosted by Italy, rotating presidency of G20, and the European Commission. In his speech, Xi urged ...
2021-05-24 09:43
3006
Trip.com Group donates 400 oxygen concentrators to India to provide support during the COVID-19 crisis
SINGAPORE, May 24, 2021 /PRNewswire/ -- Trip.com Group, a leading global online travel services provider, has launched a medical relief initiative this month to helpIndia tackle oxygen equipment shortages during the COVID-19 crisis. Trip.com Group has donated 400 oxygen concentrators to its indus...
2021-05-24 09:00
2519
A 'Game Changer' COVID-19 drug from Korea was introduced in a world class academic journal
SEOUL South Korea, May 23, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced on the 24th that CNPharm, its major shareholding bio tech company, published an article containing the research results of CP-COV03, a Niclosamide-based oral treatment for COVID-19 based on its proprietar...
2021-05-24 08:16
2348
Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea
Novavax and SK bioscience reaffirm partnership during meeting with South Korean leaders GAITHERSBURG, Md., May 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the signing of a non-...
2021-05-23 00:39
9715
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine
CAMBRIDGE, Mass. and INCHEON, South Korea, May 22, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing a fully integrated end-to-end contract develop...
2021-05-23 00:00
9561
Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response
- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test - Both new antibody tests help health care teams differentiate the cause of antibodies against SARS-CoV-2 - Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody t...
2021-05-22 05:22
9736
CGTN：China makes new pledges to help developing countries defeat COVID-19
BEIJING, May 22, 2021 /PRNewswire/ -- China on Friday announced several new measures to help developing countries tackle the COVID-19 pandemic and its sweeping impacts, pledging to contribute$3 billion in the next three years and provide more vaccines.   Addressing the Global H...
2021-05-22 01:16
4862
World Health Organisation Declares Dominica as Latest Country to Eliminate Mother-to-Child HIV Transmission
LONDON, May 21, 2021 /PRNewswire/-- The Commonwealth of Dominica has received certification from the World Health Organisation for eliminating mother-to-child HIV and syphilis transmission after witnessing no recorded cases over the last four years.Dominica is the latest Caribbean country to ach...
2021-05-21 10:00
2800
Island Pharmaceuticals granted key patent for ISLA-101 in the United States
* Island's lead asset, ISLA-101 granted key patent from United Stated Patent & Trademark Office * Patent underpins Island's drug repurposing strategy to rapidly and efficiently develop antiviral therapies with a key focus being mosquito borne viral diseases, such as dengue fever. * Around 3...
2021-05-19 19:30
2368
Eurofins Discovery Launches Human Immune Models for COVID-19 New Therapeutic Discovery or Repurposing
ST. CHARLES, Mo., May 18, 2021 /PRNewswire/ -- Eurofins Discovery, the market leader in pharmacology services and drug discovery products with over forty years providing solutions for the pharmaceutical and biotech industry, announces the launch of new services in support of clients working to ad...
2021-05-18 21:00
2016
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern
* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a modified B.1.351 S-Trimer vaccine candidate induces broad neutralization against both the original SARS-CoV-2 strain and variants of concern (VoC) including the South African variant * A single bo...
2021-05-18 11:50
3095
AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community
The "AIforCOVID Imaging Archive" platform enables the sharing of radiographic images from COVID-19 patients and development of leading-edge Artificial Intelligence-based methods for predicting clinical developments of the disease caused by SARS-CoV-2. The platform has been promoted and implement...
2021-05-18 04:44
1652
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines
PROVIDENCE, R.I., May 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces the publication"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation" in NPJ Vaccines. This research identifies peptide epitopes associated with T...
2021-05-17 20:54
2398
The Kare Lab Launches Travel Protect Kit as Travel under New Normal Resumes in 2021
HONG KONG, May 17, 2021 /PRNewswire/ -- The Kare Lab, a leading supplier in providing medical-grade protective gears to leading institutes and hospitals across the APAC, has launched a new Travel Protect Kit for worldwide travelers as vaccines are being rolled out and the world looks to resume tr...
2021-05-17 13:26
3271
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4446
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3626
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
3604
PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results
2025-12-05 21:45
3408